Status:
COMPLETED
Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
Brief Summary
This study will gather information on the safety and efficacy of patients with rheumatoid arthritis (RA) who are starting treatment with infliximab for the first time. Patients will be treated in the ...
Detailed Description
Local patients, diagnosed with RA at the National Institute of Rheumatic Diseases, Piestany, Slovakia, can participate, if their physicians have decided to treat the patient with infliximab. Registrat...
Eligibility Criteria
Inclusion
- Subject must have been given patient leaflet,
- Subject must not have ever received infliximab at the time of registration,
- Subject must be a good candidate for infliximab as per Summary of Product Characteristics
- Subject must sign the approved consent form
Exclusion
- None
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00724243
Start Date
January 1 2006
End Date
October 1 2008
Last Update
September 4 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.